Story · Medicine & Biotech

Identification of Cryptococcus neoformans capsule-associated protein antigens that mediate B cell-dependent vaccine protection in mice and elicit antibody responses in humans with cryptococcosis

2 outlets · first reported by bioRxiv - Immunology 9d ago · latest 7d ago · 48 hours of coverage

Coverage, in order

  1. 9d ago
    first bioRxiv - Immunology obscure study in animals
    Identification of Cryptococcus neoformans capsule-associated protein antigens that mediate B cell-dependent vaccine protection in mice and elicit antibody responses in humans with cryptococcosis

    Infection with the encapsulated fungal pathogen Cryptococcus neoformans causes substantial global disease burden in persons with compromised T cell function. Previously, we demonstrated that vaccines containing adjuvanted recombinant cryptococcal proteins protected mice against lethal infection by…

  2. 8d ago
    medRxiv (all subjects) obscure study
    Cross-reactive antibody and functional T-cell responses to Bundibugyo virus induced by Zaire ebolavirus vaccination and infection

    Background There is no licensed specific vaccine against the current Ebola Bundibugyo virus (BDBV) outbeak affecting the Democratic Republic of the Congo. However, clinical evaluations of a licensed Zaire ebolavirus (EBOV) vaccine have just launched. It remains unclear whether EBOV infection or…

  3. 7d ago
    medRxiv (all subjects) obscure study
    Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine

    The RTS,S vaccine provides moderate protection against malaria in children, which may be due in part to environmental factors. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are prevalent in Africa and potentially contribute to suboptimal vaccine responses. We evaluated whether…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.